UBS Group’s Molekule Group, Inc. Common Stock MKUL Stock Holding History

UBS Group’s Portfolio MKUL Stock Details MKUL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-41,348	Closed	-$6K	–	10531
2023 Q3	$6K	Buy	+41,348	New	+$61.5K	﹤0.01%	7328
2022 Q4	–	Sell	-849	Closed	-$2K	–	11430
2022 Q3	$2K	Buy	849 +435	+105%	+$2.63K	﹤0.01%	9841
2022 Q2	$5K	Buy	414 +144	+53%	+$850	﹤0.01%	8979
2022 Q1	$1K	Buy	+270	New	+$1.39K	﹤0.01%	10027

Other funds holding MKUL

FGN

Foundry Group Next Boulder, Colorado $21.1M AUM 35.51% 1-Year Est. Return

BBA

Baader Bank Aktiengesellschaft Unterschleissheim, Germany $1.33B AUM 47.35% 1-Year Est. Return

SFG

SVB Financial Group Dallas, Texas $434K AUM 277.67% 1-Year Est. Return

UBS Group's MKUL Position: Q4 2023 in Review

UBS Group sold out of Molekule Group, Inc. Common Stock (MKUL) in Q4 2023, closing a stake of 41,348 shares — an estimated $6K sold.

UBS Group first reported a position in MKUL in Q1 2022 and held it in 4 quarters. The position peaked at $6K in Q3 2023. 3 funds tracked by Wall St. Rank hold MKUL as of Q4 2023.

UBS Group reported no remaining Molekule Group, Inc. Common Stock position as of Q4 2023 after selling out during the quarter.
UBS Group sold 41,348 Molekule Group, Inc. Common Stock shares in Q4 2023, an estimated $6K.
UBS Group first reported a position in Molekule Group, Inc. Common Stock in Q1 2022 and held it in 4 quarters.
UBS Group's Molekule Group, Inc. Common Stock position peaked at $6K in Q3 2023.
3 funds tracked by Wall St. Rank held Molekule Group, Inc. Common Stock as of Q4 2023.

Based on UBS Group's 13F filing for Q4 2023, filed 9 Feb 2024.